Cite
HARVARD Citation
Trigo-Rodríguez, M. et al. (2023). Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial. Open forum infectious diseases. p. . [Online].